InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.00%
)
US TECH 100
16,790.80
(
-1.58%
)
Dow Jones
38,460.92
(
0.00%
)
Brent Oil
86.82
(
-0.46%
)
Bitcoin
63,111.52
(
-1.82%
)
Post# of 640508
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1245
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Wednesday, 12/07/2022 1:03:03 PM

Wednesday, December 07, 2022 1:03:03 PM

Post# of 640508
(ARDS) $0.90 --Phase 3 data in December ...Very low valuation of $22 million ,,positive results could push this stock toward $5


Closed enrollment in the Company’s Phase 3 study evaluating AR-301 for the treatment of Ventilator Associated Pneumonia (VAP). Aridis expects to report top-line data from this study in December 2022.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up